IMMUNOVITES Trademark

Trademark Overview

On Tuesday, July 10, 2018, a trademark application was filed for IMMUNOVITES with the United States Patent and Trademark Office. The USPTO has given the IMMUNOVITES trademark a serial number of 88031323. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, December 26, 2024. This trademark is owned by Amella Pharma, LLC. The IMMUNOVITES trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements
immunovites

General Information

Serial Number88031323
Word MarkIMMUNOVITES
Filing DateTuesday, July 10, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, December 26, 2024
Registration Number5708510
Registration DateTuesday, March 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements

Goods and ServicesDietary supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 14, 2018
Primary Code005
First Use Anywhere DateSunday, July 1, 2018
First Use In Commerce DateSunday, July 1, 2018

Trademark Owner History

Party NameAmella Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew Brunswick, NJ 08901
Party NameAmella Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816
Party NameAmella Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Wednesday, October 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 13, 2018NEW APPLICATION ENTERED
Saturday, July 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 29, 2018ASSIGNED TO EXAMINER
Tuesday, October 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 30, 2018NON-FINAL ACTION WRITTEN
Tuesday, October 30, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 30, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2018FINAL REFUSAL WRITTEN
Wednesday, November 21, 2018FINAL REFUSAL E-MAILED
Wednesday, November 21, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 21, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 28, 2018ASSIGNED TO LIE
Wednesday, November 28, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sunday, April 7, 2024TEAS SECTION 8 RECEIVED
Thursday, December 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 26, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, December 26, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

immunovites supplements dietary